[New treatment of chronic hepatitis B]
[Article in
Danish]
Affiliations
- PMID: 19087730
Item in Clipboard
[New treatment of chronic hepatitis B]
[Article in
Danish]
Ugeskr Laeger.
.
Abstract
Worldwide, 350 million people are infected with chronic hepatitis B. Over the last few years, it has been possible to treat chronic hepatitis B. Treatment very often consists of nucleos(t)ide analogs and in a few cases of pegylated alpha-interferon. In 2007, a new nucleoside analog, Telbivudine, was approved to treat chronic hepatitis B. In phase II and ongoing phase III studies, Telbivudine has proven more effective than the nucleoside analog, Lamivudine, which was very often used up until recently.
Similar articles
-
[Pharmacological agents for the treatment of chronic hepatitis B].Gastroenterol Hepatol. 2008 Mar;31(3):120-8. doi: 10.1157/13116500. Gastroenterol Hepatol. 2008. PMID: 18341843 Review. Spanish. No abstract available.
-
[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].Korean J Hepatol. 2007 Dec;13(4):503-12. doi: 10.3350/kjhep.2007.13.4.503. Korean J Hepatol. 2007. PMID: 18159148 Clinical Trial. Korean.
-
Pharmacotherapy of hepatitis B infection: a brief review.Nephrol Nurs J. 2008 Sep-Oct;35(5):507-10, 534. Nephrol Nurs J. 2008. PMID: 18856082 Review.
-
[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8. doi: 10.1016/s0213-005x(08)76517-0. Enferm Infecc Microbiol Clin. 2008. PMID: 19100229 Review. Spanish.
-
Telbivudine: a new option for the treatment of chronic hepatitis B.Expert Opin Biol Ther. 2007 May;7(5):751-61. doi: 10.1517/14712598.7.5.751. Expert Opin Biol Ther. 2007. PMID: 17477811 Review.